Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs

被引:142
作者
Lee, PJ
Langer, R
Shastri, VP [1 ]
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA
关键词
microemulsion; transdermal drug delivery; chemical enhancers; n-methyl pyrrolidone;
D O I
10.1023/A:1022283423116
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Microemulsion (ME) systems allow for the microscopic co-incorporation of aqueous and organic phase liquids. In this study, the phase diagrams of four novel ME systems were characterized. Methods. Water and IPM composed the aqueous and organic phases respectively, whereas Tween 80 served as a nonionic surfactant. Transdermal enhancers such as n-methyl pyrrolidone (NMP) and oleyl alcohol were incorporated into all systems without disruption of the stable emulsion. Results. A comparison of a W/O ME with an O/W ME of the same system for lidocaine delivery indicated that the O/W ME provides significantly greater flux (p < 0.025). The water phase was found to be a crucial component for flux of hydrophobic drugs (lidocaine free base, estradiol) as well as hydrophilic drugs (lidocaine HCl, diltiazem HCl). Furthermore, the simultaneous delivery of both a hydrophilic drug and a hydrophobic drug from the ME system is indistinguishable from either drug alone. Enhancement of drug permeability from the O/W ME system was 17-fold for lidocaine free base, 30-fold for lidocaine HCl, 58-fold for estradiol, and 520-fold for diltiazem HCl. Conclusions. The novel microemulsion systems in this study potentially offers many beneficial characteristics for transdermal drug delivery.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 25 条
[1]   Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system [J].
Baca-Estrada, ME ;
Foldvari, M ;
Ewen, C ;
Badea, I ;
Babiuk, LA .
VACCINE, 2000, 18 (17) :1847-1854
[2]  
Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77
[3]  
CHIEN YW, 1989, PHARMACEUT RES, V12, P1000
[4]   OLEIC-ACID - ITS EFFECTS ON STRATUM-CORNEUM IN RELATION TO (TRANS)DERMAL DRUG DELIVERY [J].
FRANCOEUR, ML ;
GOLDEN, GM ;
POTTS, RO .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :621-627
[5]   Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation [J].
Gorukanti, SR ;
Li, LL ;
Kim, KH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 192 (02) :159-172
[6]   Lecithin vesicular carriers for transdermal delivery of cyclosporin A [J].
Guo, JX ;
Ping, QN ;
Sun, GQ ;
Jiao, CH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (02) :201-207
[7]   Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs [J].
Ho, HO ;
Hsiao, CC ;
Sheu, MT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :138-143
[8]  
HUIBERS PD, 1996, THESIS U FLORIDA
[9]   Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery [J].
Johnson, ME ;
Mitragotri, S ;
Patel, A ;
Blankschtein, D ;
Langer, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :670-679
[10]   PERMEATION OF STEROIDS THROUGH HUMAN SKIN [J].
JOHNSON, ME ;
BLANKSCHTEIN, D ;
LANGER, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (09) :1144-1146